I can add something on the clinical side, if I may.
There's been some pioneering work done by one of our McGill psychiatrists showing that some beta blockers, used at strategic times after PTSD is manifested, will suppress some of the long-lasting effects. So there is a start to pharmacological manipulation using old drugs to perhaps modify the longer-term impact. That would be under an operating grant in the single-applicant category of funding. But it could also be, perhaps for the veterans, a targeted program for the prevention of cognitive decline in Canadians who served overseas and have PTSD.